BCM
EW icon

Boreal Capital Management’s Edwards Lifesciences EW Stock Holding History

Boreal Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9K Hold
120
– – 0.01% 328
2026
Q1 		$9.61K Hold
120
– – 0.01% 339
2025
Q4 		$10.2K Hold
120
– – 0.01% 339
2025
Q3 		$9.33K Hold
120
– – 0.01% 365
2025
Q2 		$9.38K Buy
+120
New +$8.95K 0.01% 352

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Boreal Capital Management's EW Position: Q2 2026 in Review

Boreal Capital Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 120 shares worth $10.9K. The position accounts for 0.01% of the portfolio, ranked #328.

Boreal Capital Management first reported a position in EW in Q2 2025 and has held it in 5 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Boreal Capital Management held 120 shares of Edwards Lifesciences worth $10.9K as of Q2 2026.
  • Boreal Capital Management left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Boreal Capital Management's portfolio in Q2 2026, its #328 holding.
  • Boreal Capital Management first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 5 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Boreal Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.